This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Snu Rdb Foundation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Dong Jae Baek: Innovator in Immune Adjuvants
Introduction
Dong Jae Baek is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology through his innovative research and development of novel pharmaceutical compositions.
Latest Patents
Dong Jae Baek holds a patent for his work on α-galactosylceramide derivatives, which includes pharmaceutically acceptable salts, preparation methods, and pharmaceutical compositions for use as immune adjuvants. This patent discloses novel derivatives where the amide moiety of α-GalCer is bioisosterically replaced with a triazole moiety. These derivatives are designed to direct cytokine secretion toward IL-4 rather than IFN-γ, making them potential therapeutic agents for autoimmune diseases regulated by IL-4, such as type 1 diabetes and multiple sclerosis. He has 1 patent to his name.
Career Highlights
Dong Jae Baek is associated with the Snur & Db Foundation, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in treating various autoimmune conditions.
Collaborations
He collaborates with notable colleagues, including Chang-Yuil Kang and Sanghee Kim, who contribute to his research endeavors.
Conclusion
Dong Jae Baek's innovative work in developing immune adjuvants showcases his commitment to advancing medical science and improving therapeutic options for autoimmune diseases. His contributions are paving the way for future research and development in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile